Basilea shareholders approve all proposals of the board of directors at the annual general meeting
Allschwil, Switzerland, April 24, 2024 Basilea Pharmaceutica Ltd, Allschwil , a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal...